Benoxaprofen
(Synonyms: 氧苯恶唑丙酸,LRCL 3794) 目录号 : GC49836An NSAID
Cas No.:51234-28-7
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Benoxaprofen is a non-steroidal anti-inflammatory drug.1 It inhibits prostaglandin E2 and leukotriene C4 production in isolated mouse peritoneal macrophages stimulated with A23187 when used at a concentration of 100 µM.2 Benoxaprofen (25 and 50 µg/ml) inhibits serum-induced chemotaxis of isolated rat peritoneal leukocytes.3 It induces hemolysis in isolated human erythrocytes and histamine release in isolated rat peritoneal mast cells in a light-dependent manner when used at a concentration of 10 µM.4 Benoxaprofen reduces carrageenan-induced paw edema and yeast-induced fever in rats and acetic acid-induced writhing in mice in a dose-dependent manner.1 Formulations containing benoxaprofen have previously been used in the treatment of osteoarthritis and rheumatoid arthritis.
1.Cashin, C.H., Dawson, W., and Kitchen, E.A.The pharmacology of benoxaprofen (2-[4-chlorophenyl]-α-methyl-5-benzoxazole acetic acid), LRCL 3794, a new compound with antiinflammatory activity apparently unrelated to inhibition of prostaglandin synthesisJ. Pharm. Pharmacol.29(6)330-336(1977) 2.Brune, K., Aehringhaus, U., and Peskar, B.A.Pharmacological control of leukotriene and prostaglandin production from mouse peritoneal macrophagesAgents Actions14(5-6)729-734(1984) 3.Meacock, S.C., and Kitchen, E.A.Effects of the non-steroidal anti-inflammatory drug benoxaprofen on leucocyte migrationJ. Pharm. Pharmacol.31(6)366-370(1979) 4.Sik, R.H., Paschall, C.S., and Chignell, C.F.The phototoxic effect of benoxaprofen and its analogs on human erythrocytes and rat peritoneal mast cellsPhotochem. Photobiol.38(4)411-415(1983)
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.3146 mL | 16.5728 mL | 33.1455 mL |
5 mM | 0.6629 mL | 3.3146 mL | 6.6291 mL |
10 mM | 0.3315 mL | 1.6573 mL | 3.3146 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。